Navigation Links
Golden Meditech Chairman Increases Stake in Company
Date:3/31/2011

HONG KONG, March 31, 2011 /PRNewswire-Asia/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Company," - 801.HK; 910801.TW) wishes to announce that the Group's Chairman, Mr. KAM Yuen and his family has purchased 11.532 million shares of the Company on March 29 & 30, 2011, at the average price of HK$1.3152 per share via a representative holding company, as per disclosed to the Hong Kong Exchanges and Clearings Limited.  As a result of which, Mr. Kam and family have increased their interest in the Company from 19.88% to 20.49%.

Mr. Kam is the founder of the Company with over 20 years of experience in healthcare industry in China.  Under his helm, the Group has grown from a single product medical devices producer to being a leading healthcare enterprise in China and a leader in multiple markets, including medical devices, healthcare management and cord blood banking.

About Golden Meditech Holdings LimitedGolden Meditech Holdings Limited is China's leading integrated-healthcare device and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx).  Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets over the years, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities.  Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

For enquiries, please contact:Investor Relations DepartmentGolden Meditech Holdings LimitedAddress:  48/F, Bank of China Tower, 1 Garden Road, Central, Hong KongTel:  +852 3605 8180Fax:  +852 3605 8181Email: ir@goldenmeditech.com
'/>"/>

SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China
2. Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business
3. Golden Meditech to Form Strategic Alliance with Long Bon International
4. Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering
5. Golden Meditech Announces Plan to Issue Taiwan Depository Receipts
6. Golden Meditech Announces Annual Results for FY 2009/10
7. Biodel Announces Appointment of Dr. Brian J.G. Pereira as Board Chairman; Dr. Charles A. Sanders to Remain on Board
8. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
9. Giant Eagle® Receives American Diabetes Association Chairmans Citation Award
10. Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
11. MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology:
(Date:5/6/2016)... , ... May 06, 2016 , ... ... arrival of Sovaldi, which made headlines mostly for its cost despite its potential ... and moral questions surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have ...
(Date:5/6/2016)... ... 2016 , ... RowdMap, Inc. co-founder, Joshua Rosenthal, PhD, joins ... Deputy Administrator at Centers for Medicare and Medicaid Services (CMS); Ali Khan, MD, ... Officer at Health Care Service Corporation (Blue Cross and Blue Shield of Illinois, ...
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... the Responsible Wool Standard (RWS) for public stakeholder review. The stakeholder review is an ... that it meets its goals and delivers value to the wool industry., The RWS ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May 6 - ... on steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted in ... will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with ...
(Date:5/5/2016)... Indianapolis, IN (PRWEB) , ... May 05, 2016 ... ... employee benefits advisory organization, announces McLaughlin & Smoak Benefits as the latest addition ... & Smoak Benefits has a dedicated team of compliance, wellness, human resources, and ...
Breaking Medicine News(10 mins):